FNA Paragon 28 Inc

USD 10.05 0.26 2.655771
Icon

Paragon 28 Inc (FNA) Stock Analysis and Price Targets

COMMON STOCK | Medical Devices | NYE
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 10.05

+0.26 (+2.66)%

USD 0.81B

0.37M

USD 16.83(+67.50%)

N/A

Icon

FNA

Paragon 28 Inc (USD)
COMMON STOCK | NYE
USD 10.05
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.81B

N/A

USD 10.05

Paragon 28 Inc (FNA) Stock Forecast

Show ratings and price targets of :
USD 16.83
(+67.50%)

Based on the Paragon 28 Inc stock forecast from 3 analysts, the average analyst target price for Paragon 28 Inc is USD 16.83 over the next 12 months. Paragon 28 Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Paragon 28 Inc is Bearish, which is based on 2 positive signals and 8 negative signals. At the last closing, Paragon 28 Inc’s stock price was USD 10.05. Paragon 28 Inc’s stock price has changed by +4.25% over the past week, +6.80% over the past month and -45.20% over the last year.

No recent analyst target price found for Paragon 28 Inc
No recent average analyst rating found for Paragon 28 Inc

Company Overview Paragon 28 Inc

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion ...Read More

https://paragon28.com

14445 Grasslands Drive, Englewood, CO, United States, 80112

574

December

USD

USA

Adjusted Closing Price for Paragon 28 Inc (FNA)

Loading...

Unadjusted Closing Price for Paragon 28 Inc (FNA)

Loading...

Share Trading Volume for Paragon 28 Inc Shares

Loading...

Compare Performance of Paragon 28 Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for FNA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Paragon 28 Inc (Sector: Medical Devices )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ABT
Abbott Laboratories +0.52 (+0.49%) USD185.79B 33.36 18.75

ETFs Containing FNA

Symbol Name FNA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Paragon 28 Inc (FNA) Stock

Based on ratings from 3 analysts Paragon 28 Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 6 buy, sell and hold ratings.

Unfortunately we do not have enough data on FNA's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for FNA is USD 16.83 over the next 12 months. The maximum analyst target price is USD 18 while the minimum anlayst target price is USD 14.

FNA stock's Price/Earning ratio is 460.06. Our analysis grades FNA stock's Price / Earning ratio at F. This means that FNA stock's Price/Earning ratio is above 96% of the stocks in the Medical Devices sector in the NYE exchange. Based on this FNA may be a overvalued for its sector.

The last closing price of FNA's stock was USD 10.05.

The most recent market capitalization for FNA is USD 0.81B.

Based on targets from 3 analysts, the average taret price for FNA is projected at USD 16.83 over the next 12 months. This means that FNA's stock price may go up by +67.50% over the next 12 months.

We can't find any ETFs which contains Paragon 28 Inc's stock.

As per our most recent records Paragon 28 Inc has 574 Employees.

Paragon 28 Inc's registered address is 14445 Grasslands Drive, Englewood, CO, United States, 80112. You can get more information about it from Paragon 28 Inc's website at https://paragon28.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...